<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>Medicine</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/60D53EED-AF3D-4466-9F4B-B04C5C9ADFD9"><gtr:id>60D53EED-AF3D-4466-9F4B-B04C5C9ADFD9</gtr:id><gtr:name>Peptide Protein Research Ltd</gtr:name><gtr:address><gtr:line1>Bridge House Farm</gtr:line1><gtr:line2>184 Funtley Road</gtr:line2><gtr:line3>Funtley</gtr:line3><gtr:postCode>PO15 6DP</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/7F938FA6-53D7-4A93-8F87-ED501A060712"><gtr:id>7F938FA6-53D7-4A93-8F87-ED501A060712</gtr:id><gtr:firstName>Stephen</gtr:firstName><gtr:otherNames>Paul</gtr:otherNames><gtr:surname>Wood</gtr:surname><gtr:roles><gtr:role><gtr:name>TRAINING_GRANT_HOLDER</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BB%2FH015809%2F1"><gtr:id>9165B219-D2CC-4AFE-B175-ECC771DEBE61</gtr:id><gtr:title>Synthesis and characterisation of amyloid fibre motifs and mimetics participating in cooperative binding with serum amyloid p component.</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Training Grant</gtr:grantCategory><gtr:grantReference>BB/H015809/1</gtr:grantReference><gtr:abstractText>The plasma glycoprotein, serum amyloid p component (SAP) binds to amyloid fibres wherever they are deposited in diseased tissues. More than twenty different proteins are known to form fibres. SAP does not bind to any of the proteins in their native state. Therefore the fibre recognition motif must arise from the structural transition that takes place during fibre formation. SAP may be involved in promoting fibre deposition and is known to stabilise fibres, protecting them against proteolytic attack and digestion by phagocytic cells. The interaction therefore appears to be a good target for amyloid clearing drugs. SAP is pentameric and each Mr 23500 subunit carries a double calcium site that is believed to be the amyloid recognition site. Small molecules such as phosphoethanolamine or D-proline bind to this site with modest affinity (Kd 20-40 micromolar) via their acidic components binding the calcium ions. The experimental drug CPHPC (Pepys et al Nature 2002) is a bivalent compound comprising two D-proline residues linked through their N termini via a six carbon aliphatic chain. This compound crosslinks pairs of SAP molecules forming a decameric complex where five drug molecules interact with ten SAP subunits. The cooperativity of this mode of binding enhances the affinity of the interaction by three orders (Kd 10 nano-molar). The resulting decamers of SAP are rapidly cleared by the liver in vivo but the compound has insuffient affinity to completely strip all SAP from fibre deposits. The aim of this project is to synthesise cyclic peptides carrying five D-proline arms on one face or ten D-proline arms distributed on both faces. The hypothesis is that these compounds should bind to SAP in a calcium dependent manner with enhanced cooperativity and high affinity, forming pentameric SAP with blocked fibre recognition sites or crosslinked decamers. Dr Broadbridge has extensive experience in preparing a wide spectrum of different cyclic peptides and this phase of the training will be carried out in his lab. at Peptide Protein Research Ltd. The binding of these products to SAP will be characterised by calorimetry at UCL and the potential mode of binding investigated by computer graphic investigation of SAP and the binding sites for D-proline head groups. The materials will be co-crystallised with SAP and the detailed structure of the interaction investigated by X-ray analysis. We will also investigate peptide sequences likely to be exposed on the surface of fibres. Structural studies on Abeta 1-42 and H/D exchange measurements on transthyretin and beta2 - microglobulin suggest likely regions that are exposed on fibres. The results of the work will provide new tools for investigating fibre formation and contribute to the design of more effective blockers of this process.</gtr:abstractText><gtr:fund><gtr:end>2014-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2010-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>83281</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">BB/H015809/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>